Skip to main content
TipRanks
Go Ultimate75% OFF

Dennis Winger Insider Profile

4 Followers

Dennis Winger, Director at Nektar Therapeutics, holds 47.75K shares in Nektar Therapeutics (Ticker: NKTR), holds 162.18K shares in Accuray (Ticker: ARAY), holds 4.64K shares in Pacira Pharmaceuticals (Ticker: PCRX).

Dennis Winger's Trading History

NKTR
Nektar Therapeutics
Aug 21, 2018DirectorUninformative Buy427.80K$1.78M
ARAY
Accuray
Dec 04, 2017DirectorUninformative Buy―$454.11K
PCRX
Pacira Pharmaceuticals
Jun 16, 2017DirectorUninformative Buy―$169.36K
VRTX
Vertex Pharmaceuticals
Mar 12, 2012DirectorUninformative Buy1.32M$3.50M
HRTX
Heron Therapeutics
―Director―$21.56K

You May Also Like

Dennis Winger insider profile FAQ

What is the percentage of profitable transactions made by Dennis Winger?
The percentage of profitable transactions made by Dennis Winger is 67%.
What is the average return per transaction made by Dennis Winger?
The average return per transaction made by Dennis Winger is 36.30%.
What stocks does Dennis Winger hold?
Dennis Winger holds: NKTR, ARAY, PCRX, HRTX, VRTX stocks.
What was Dennis Winger’s latest transaction?
Dennis Winger’s latest transaction was an Uninformative Buy of $427.80K.
What was Dennis Winger's most profitable transaction?
Dennis Winger’s most profitable transaction was an Informative Sell of NKTR stock on August 21, 2018. The return on the trade was 72.50%.
What is Dennis Winger's role in Nektar Therapeutics?
Dennis Winger's role in Nektar Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.